Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-067659
Filing Date
2017-12-29
Accepted
2017-12-29 17:11:19
Documents
1
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3886
  Complete submission text file 0001209191-17-067659.txt   5571
Mailing Address 325 CENTRAL PARK W APT 38 NEW YORK NY 10025
Business Address
SCHEINBERG DAVID A (Reporting) CIK: 0001250316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 171282653

Mailing Address 2000 CROW CANYON PLACE SUITE 380 SAN RAMON CA 94583
Business Address 2000 CROW CANYON PLACE SUITE 380 SAN RAMON CA 94583 855 855 GALE
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations